Santafé Manel M, Lanuza M Angel, Garcia Neus, Tomàs Josep
Unitat d'Histologia i Neurobiologia (UHN), Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, carrer St. Llorenç num 21, 43201-Reus, Spain.
Eur J Neurosci. 2006 Apr;23(8):2048-56. doi: 10.1111/j.1460-9568.2006.04753.x.
We have used intracellular recording to investigate the existence of a functional link between muscarinic presynaptic acetylcholine (ACh) autoreceptors, the intracellular serine-threonine kinases-mediated transduction pathways and transmitter release in the motor nerve terminals of adult rats. We found the following. (1) Transmitter release was reduced by the M1 muscarinic acetylcholine receptor (mAChR) blocker pirenzepine and enhanced by the M2 blocker methoctramine. The unselective mAChR blocker atropine increased ACh release, which suggests the unmasking of another parallel release-potentiating mechanism. There are therefore two opposite, though finely balanced, M1-M2 mAChR-operated mechanisms that tonically modulate transmitter release. (2) Both M1 and M2 mechanisms were altered when protein kinase C (PKC), protein kinase A (PKA) or the P/Q-type calcium channel were blocked. (3) Both PKC and PKA potentiated release when they were specifically stimulated [with phorbol 12-myristate 13-acetate (PMA) and Sp-8-Br cAMPs, respectively], and both needed the P/Q channel. (4) In normal conditions PKC seemed not to be directly involved in transmitter release (the PKC blocker calphostin C did not reduce release), whereas PKA was coupled to potentiate release (the PKA blocker H-89 reduced release). However, when an imbalance of the M1-M2 mAChRs function was experimentally produced with selective blockers, an inversion of the kinase function occurred and PKC could then stimulate transmitter release, whereas PKA was uncoupled. (5) The muscarinic function may be explained by the existence of an M1-mediated increased PKC activity-dependent potentiation of release and an M2-mediated PKA decreased activity-dependent release reduction. These findings show that there is a precise interrelation pattern of the mAChRs, PKC and PKA in the control of the neurotransmitter release.
我们利用细胞内记录技术来研究成年大鼠运动神经末梢中,毒蕈碱型突触前乙酰胆碱(ACh)自身受体、细胞内丝氨酸 - 苏氨酸激酶介导的转导途径与递质释放之间是否存在功能联系。我们发现如下情况:(1)毒蕈碱型乙酰胆碱受体(mAChR)的M1阻滞剂哌仑西平可减少递质释放,而M2阻滞剂甲溴东莨菪碱可增强递质释放。非选择性mAChR阻滞剂阿托品可增加ACh释放,这表明另一种平行的释放增强机制被揭示。因此,存在两种相反但精细平衡的由M1 - M2 mAChR调控的机制,它们持续调节递质释放。(2)当蛋白激酶C(PKC)、蛋白激酶A(PKA)或P/Q型钙通道被阻断时,M1和M2机制均发生改变。(3)当PKC和PKA分别用佛波醇12 - 肉豆蔻酸酯13 - 乙酸酯(PMA)和Sp - 8 - Br cAMPs特异性刺激时,二者均增强释放,且二者都需要P/Q通道。(4)在正常情况下,PKC似乎不直接参与递质释放(PKC阻滞剂钙泊三醇C不减少释放),而PKA与增强释放相关联(PKA阻滞剂H - 89减少释放)。然而,当用选择性阻滞剂实验性地造成M1 - M2 mAChRs功能失衡时,激酶功能发生反转,此时PKC可刺激递质释放,而PKA则失去关联。(5)毒蕈碱功能可能是由于存在一种由M1介导的、依赖PKC活性增加的释放增强作用以及一种由M2介导的、依赖PKA活性降低的释放减少作用。这些发现表明,在神经递质释放的控制中,mAChRs、PKC和PKA之间存在精确的相互关系模式。